https://www.washingtonpost.com/world/2020/09/08/bergamo-italy-covid-longterm/ 30% left with lung damage
- Forums
- ASX - By Stock
- CYC
- Ann: Technegas USA Trial Successfully Meets Primary Endpoint
Ann: Technegas USA Trial Successfully Meets Primary Endpoint, page-10
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.66 |
Change
-0.030(1.78%) |
Mkt cap ! $185.5M |
Open | High | Low | Value | Volume |
$1.67 | $1.67 | $1.66 | $44.60K | 26.70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 597 | $1.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 310 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 598 | 1.660 |
2 | 5273 | 1.650 |
3 | 5102 | 1.630 |
1 | 3000 | 1.620 |
1 | 5000 | 1.600 |
Price($) | Vol. | No. |
---|---|---|
1.685 | 310 | 1 |
1.690 | 19414 | 1 |
1.710 | 2438 | 1 |
1.715 | 1260 | 1 |
1.720 | 14782 | 1 |
Last trade - 15.34pm 15/07/2024 (20 minute delay) ? |
Featured News
CYC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online